nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—abdominal aortic aneurysm	0.896	1	CbGaD
Danazol—CCL2—tunica intima—abdominal aortic aneurysm	0.017	0.318	CbGeAlD
Danazol—CCL2—artery—abdominal aortic aneurysm	0.00583	0.109	CbGeAlD
Danazol—SHBG—hindlimb—abdominal aortic aneurysm	0.00555	0.103	CbGeAlD
Danazol—CCL2—blood plasma—abdominal aortic aneurysm	0.00437	0.0816	CbGeAlD
Danazol—PGR—artery—abdominal aortic aneurysm	0.00306	0.0571	CbGeAlD
Danazol—SHBG—blood plasma—abdominal aortic aneurysm	0.00255	0.0476	CbGeAlD
Danazol—CCL2—connective tissue—abdominal aortic aneurysm	0.00233	0.0434	CbGeAlD
Danazol—CCL2—Vitamin B12 Metabolism—LDLR—abdominal aortic aneurysm	0.00201	0.04	CbGpPWpGaD
Danazol—CCL2—kidney—abdominal aortic aneurysm	0.00198	0.037	CbGeAlD
Danazol—CCL2—Oncostatin M Signaling Pathway—LDLR—abdominal aortic aneurysm	0.00166	0.033	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.00164	0.0326	CbGpPWpGaD
Danazol—CCL2—spinal cord—abdominal aortic aneurysm	0.00154	0.0288	CbGeAlD
Danazol—SHBG—connective tissue—abdominal aortic aneurysm	0.00136	0.0253	CbGeAlD
Danazol—CCL2—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.0013	0.0259	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—SOD2—abdominal aortic aneurysm	0.00127	0.0253	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—NOS2—abdominal aortic aneurysm	0.00125	0.025	CbGpPWpGaD
Danazol—PGR—connective tissue—abdominal aortic aneurysm	0.00122	0.0228	CbGeAlD
Danazol—CCL2—IL1 and megakaryotyces in obesity—MMP9—abdominal aortic aneurysm	0.00114	0.0228	CbGpPWpGaD
Danazol—CCL2—IL1 and megakaryotyces in obesity—NFKB1—abdominal aortic aneurysm	0.00113	0.0225	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.00111	0.0221	CbGpPWpGaD
Danazol—CYP19A1—connective tissue—abdominal aortic aneurysm	0.0011	0.0205	CbGeAlD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—abdominal aortic aneurysm	0.00108	0.0214	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—APOE—abdominal aortic aneurysm	0.00104	0.0207	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.00103	0.0206	CbGpPWpGaD
Danazol—GNRHR—Peptide GPCRs—AGTR1—abdominal aortic aneurysm	0.00103	0.0204	CbGpPWpGaD
Danazol—CYP3A4—blood plasma—abdominal aortic aneurysm	0.001	0.0187	CbGeAlD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—abdominal aortic aneurysm	0.000986	0.0196	CbGpPWpGaD
Danazol—AR—connective tissue—abdominal aortic aneurysm	0.000975	0.0182	CbGeAlD
Danazol—ESR1—connective tissue—abdominal aortic aneurysm	0.000957	0.0179	CbGeAlD
Danazol—AR—kidney—abdominal aortic aneurysm	0.00083	0.0155	CbGeAlD
Danazol—CCL2—AP-1 transcription factor network—AGT—abdominal aortic aneurysm	0.000825	0.0164	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.000821	0.0163	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.000817	0.0163	CbGpPWpGaD
Danazol—ESR1—kidney—abdominal aortic aneurysm	0.000815	0.0152	CbGeAlD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—abdominal aortic aneurysm	0.000809	0.0161	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.0008	0.0159	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—MMP9—abdominal aortic aneurysm	0.000731	0.0145	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000723	0.0144	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.000673	0.0134	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.000665	0.0132	CbGpPWpGaD
Danazol—AR—spinal cord—abdominal aortic aneurysm	0.000646	0.0121	CbGeAlD
Danazol—CCL2—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.000619	0.0123	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.000592	0.0118	CbGpPWpGaD
Danazol—CCL2—IL-1 signaling pathway—NFKB1—abdominal aortic aneurysm	0.000583	0.0116	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.000581	0.0116	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.000531	0.0106	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000528	0.0105	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.000527	0.0105	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00051	0.0101	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.000504	0.01	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.000496	0.00987	CbGpPWpGaD
Danazol—GNRHR—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.000488	0.00972	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—MMP9—abdominal aortic aneurysm	0.000486	0.00967	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000461	0.00918	CbGpPWpGaD
Danazol—CYP3A4—kidney—abdominal aortic aneurysm	0.000455	0.00848	CbGeAlD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—abdominal aortic aneurysm	0.000444	0.00883	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.000443	0.00881	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.000437	0.00869	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.000405	0.00806	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.0004	0.00797	CbGpPWpGaD
Danazol—ESR1—Estrogen signaling pathway—NFKB1—abdominal aortic aneurysm	0.000396	0.00789	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.000389	0.00775	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000386	0.00769	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.000371	0.00738	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.000365	0.00726	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000354	0.00704	CbGpPWpGaD
Danazol—GNRHR—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.000344	0.00684	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—abdominal aortic aneurysm	0.000336	0.00668	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—MMP2—abdominal aortic aneurysm	0.000329	0.00655	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—abdominal aortic aneurysm	0.000326	0.0065	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000323	0.00644	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.00032	0.00637	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000307	0.00612	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.000302	0.006	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—NOS2—abdominal aortic aneurysm	0.000292	0.00582	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—CDKN2A—abdominal aortic aneurysm	0.00029	0.00578	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—AGT—abdominal aortic aneurysm	0.000279	0.00556	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.000269	0.00536	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.000262	0.00522	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—abdominal aortic aneurysm	0.000255	0.00508	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—abdominal aortic aneurysm	0.000252	0.00502	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—MMP2—abdominal aortic aneurysm	0.000251	0.00499	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000249	0.00495	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—abdominal aortic aneurysm	0.000248	0.00493	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.000246	0.0049	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—abdominal aortic aneurysm	0.000234	0.00465	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CCL2—abdominal aortic aneurysm	0.00023	0.00458	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.000229	0.00455	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000228	0.00453	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.000228	0.00453	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000227	0.00452	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000208	0.00413	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.0002	0.00399	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—abdominal aortic aneurysm	0.000192	0.00382	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—abdominal aortic aneurysm	0.000191	0.0038	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000189	0.00377	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000187	0.00373	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000173	0.00345	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—NFKB1—abdominal aortic aneurysm	0.000166	0.00331	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MMP9—abdominal aortic aneurysm	0.000164	0.00327	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—NFKB1—abdominal aortic aneurysm	0.000154	0.00306	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000143	0.00285	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000143	0.00284	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000139	0.00277	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000138	0.00275	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000134	0.00267	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—AGT—abdominal aortic aneurysm	0.000133	0.00265	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000131	0.00261	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000126	0.00252	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000123	0.00245	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000123	0.00244	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000114	0.00227	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000113	0.00224	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.000111	0.00221	CbGpPWpGaD
Danazol—PGR—Gene Expression—AAAS—abdominal aortic aneurysm	0.00011	0.0022	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00011	0.0022	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000109	0.00217	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000109	0.00216	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—MMP2—abdominal aortic aneurysm	0.000104	0.00208	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000102	0.00202	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LDLR—abdominal aortic aneurysm	9.94e-05	0.00198	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	9.82e-05	0.00196	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AGT—abdominal aortic aneurysm	9.79e-05	0.00195	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AGT—abdominal aortic aneurysm	9.72e-05	0.00194	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	9.46e-05	0.00188	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NCF1—abdominal aortic aneurysm	9.3e-05	0.00185	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AGT—abdominal aortic aneurysm	8.89e-05	0.00177	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	8.79e-05	0.00175	CbGpPWpGaD
Danazol—AR—Gene Expression—AAAS—abdominal aortic aneurysm	8.41e-05	0.00167	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	8.4e-05	0.00167	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LRP1—abdominal aortic aneurysm	8.27e-05	0.00165	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	8.16e-05	0.00163	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—SERPINE1—abdominal aortic aneurysm	8.14e-05	0.00162	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—P2RY12—abdominal aortic aneurysm	7.74e-05	0.00154	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	7.47e-05	0.00149	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL2—abdominal aortic aneurysm	7.33e-05	0.00146	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	7.29e-05	0.00145	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP3—abdominal aortic aneurysm	7.28e-05	0.00145	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP3—abdominal aortic aneurysm	6.66e-05	0.00132	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AAAS—abdominal aortic aneurysm	6.48e-05	0.00129	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LDLR—abdominal aortic aneurysm	6.27e-05	0.00125	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—SERPINE1—abdominal aortic aneurysm	6.2e-05	0.00123	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NCF1—abdominal aortic aneurysm	5.86e-05	0.00117	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	5.83e-05	0.00116	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AGT—abdominal aortic aneurysm	5.74e-05	0.00114	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	5.72e-05	0.00114	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AAAS—abdominal aortic aneurysm	5.63e-05	0.00112	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—abdominal aortic aneurysm	5.63e-05	0.00112	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AGT—abdominal aortic aneurysm	5.25e-05	0.00105	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—abdominal aortic aneurysm	5.15e-05	0.00102	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—LDLR—abdominal aortic aneurysm	4.92e-05	0.000978	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LRP1—abdominal aortic aneurysm	4.85e-05	0.000966	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—SERPINE1—abdominal aortic aneurysm	4.78e-05	0.000951	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	4.71e-05	0.000937	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	4.54e-05	0.000904	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.42e-05	0.000879	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.33e-05	0.000861	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP3—abdominal aortic aneurysm	4.2e-05	0.000835	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.04e-05	0.000804	CbGpPWpGaD
Danazol—PGR—Gene Expression—SERPINE1—abdominal aortic aneurysm	3.92e-05	0.00078	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	3.92e-05	0.00078	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LDLR—abdominal aortic aneurysm	3.68e-05	0.000732	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NCF1—abdominal aortic aneurysm	3.44e-05	0.000685	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.38e-05	0.000673	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.35e-05	0.000666	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AGT—abdominal aortic aneurysm	3.31e-05	0.00066	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—abdominal aortic aneurysm	3.25e-05	0.000646	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.09e-05	0.000616	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.06e-05	0.000609	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—abdominal aortic aneurysm	2.99e-05	0.000594	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	2.76e-05	0.00055	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—abdominal aortic aneurysm	2.73e-05	0.000543	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AGT—abdominal aortic aneurysm	2.6e-05	0.000517	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	2.55e-05	0.000507	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—abdominal aortic aneurysm	2.55e-05	0.000507	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP3—abdominal aortic aneurysm	2.46e-05	0.00049	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—abdominal aortic aneurysm	2.3e-05	0.000458	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—abdominal aortic aneurysm	1.95e-05	0.000388	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AGT—abdominal aortic aneurysm	1.94e-05	0.000387	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.93e-05	0.000384	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—abdominal aortic aneurysm	1.91e-05	0.000379	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—abdominal aortic aneurysm	1.74e-05	0.000347	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	1.64e-05	0.000327	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—abdominal aortic aneurysm	1.6e-05	0.000319	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	1.5e-05	0.000298	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	1.43e-05	0.000286	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—abdominal aortic aneurysm	1.15e-05	0.000228	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	1.13e-05	0.000226	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	7.58e-06	0.000151	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	7.43e-06	0.000148	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	5.09e-06	0.000101	CbGpPWpGaD
